Latest Insider Transactions at Bio Techne Corp (TECH)
This section provides a real-time view of insider transactions for Bio Techne Corp (TECH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIO-TECHNE Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIO-TECHNE Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2021
|
Charles R. Kummeth Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,481
-2.15%
|
$3,358,969
$449.6 P/Share
|
|
Jun 09
2021
|
Kim Kelderman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
811
-100.0%
|
$351,163
$433.0 P/Share
|
|
Jun 07
2021
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
9,942
-11.43%
|
$4,195,524
$422.27 P/Share
|
|
Jun 07
2021
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,942
+34.26%
|
$1,053,852
$106.59 P/Share
|
|
May 25
2021
|
Charles R. Kummeth Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,305
-10.89%
|
$8,948,100
$420.12 P/Share
|
|
May 25
2021
|
Charles R. Kummeth Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,849
+15.85%
|
$3,463,806
$94.35 P/Share
|
|
May 25
2021
|
Kim Kelderman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
845
-51.03%
|
$358,280
$424.0 P/Share
|
|
May 01
2021
|
Kim Kelderman Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
856
-34.08%
|
$365,512
$427.49 P/Share
|
|
May 01
2021
|
Kim Kelderman Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,667
+39.89%
|
-
|
|
Feb 16
2021
|
Charles R. Kummeth Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,428
-9.89%
|
$7,162,908
$411.0 P/Share
|
|
Feb 16
2021
|
Charles R. Kummeth Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+14.54%
|
$2,820,000
$94.35 P/Share
|
|
Feb 12
2021
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
10,000
-38.29%
|
$3,980,000
$398.76 P/Share
|
|
Feb 12
2021
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.28%
|
$1,060,000
$106.59 P/Share
|
|
Feb 12
2021
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
10,000
-27.64%
|
$4,000,000
$400.92 P/Share
|
|
Feb 12
2021
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.32%
|
$1,060,000
$106.59 P/Share
|
|
Feb 08
2021
|
Roeland Nusse Director |
SELL
Open market or private sale
|
Direct |
6,000
-47.0%
|
$2,310,000
$385.08 P/Share
|
|
Feb 08
2021
|
Roeland Nusse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+19.78%
|
$408,000
$68.63 P/Share
|
|
Feb 05
2021
|
Norman David Eansor President-Protein Sciences |
SELL
Open market or private sale
|
Direct |
32,933
-35.67%
|
$12,547,473
$381.75 P/Share
|
|
Feb 05
2021
|
Norman David Eansor President-Protein Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
32,933
+41.62%
|
$3,490,898
$106.59 P/Share
|
|
Feb 05
2021
|
Kim Kelderman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
823
-49.34%
|
$319,324
$388.45 P/Share
|
|
Jan 15
2021
|
Charles R. Kummeth Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-12.03%
|
$6,880,000
$344.0 P/Share
|
|
Jan 11
2021
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
10,000
-11.1%
|
$3,320,000
$332.19 P/Share
|
|
Jan 11
2021
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.32%
|
$1,060,000
$106.59 P/Share
|
|
Dec 07
2020
|
Charles R. Kummeth Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.92%
|
$1,540,000
$308.0 P/Share
|
|
Nov 30
2020
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
10,857
-26.67%
|
$3,278,814
$302.1 P/Share
|
|
Nov 30
2020
|
Brenda S. Furlow SVP - GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
11,795
+22.8%
|
$1,250,270
$106.59 P/Share
|
|
Nov 18
2020
|
Robert V Baumgartner Director |
SELL
Open market or private sale
|
Direct |
5,000
-34.22%
|
$1,515,000
$303.33 P/Share
|
|
Nov 18
2020
|
Robert V Baumgartner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+25.49%
|
$330,000
$66.9 P/Share
|
|
Nov 11
2020
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
7,391
-24.4%
|
$2,269,037
$307.35 P/Share
|
|
Nov 11
2020
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,391
+30.9%
|
$783,446
$106.59 P/Share
|
|
Nov 09
2020
|
Alpna Seth Director |
SELL
Open market or private sale
|
Direct |
5,023
-41.05%
|
$1,537,038
$306.35 P/Share
|
|
Nov 09
2020
|
Alpna Seth Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,023
+31.18%
|
$763,496
$152.45 P/Share
|
|
Nov 09
2020
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
3,600
-6.36%
|
$1,112,400
$309.86 P/Share
|
|
Nov 09
2020
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,600
+22.04%
|
$381,600
$106.59 P/Share
|
|
Nov 06
2020
|
John L Higgins Director |
SELL
Open market or private sale
|
Direct |
5,000
-20.78%
|
$1,495,000
$299.96 P/Share
|
|
Nov 06
2020
|
John L Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+34.69%
|
$350,000
$70.35 P/Share
|
|
Nov 06
2020
|
Randolph C Steer Director |
SELL
Open market or private sale
|
Direct |
10,000
-16.13%
|
$3,010,000
$301.97 P/Share
|
|
Nov 06
2020
|
Randolph C Steer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+28.97%
|
$680,000
$68.63 P/Share
|
|
Nov 06
2020
|
Charles R. Kummeth Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,375
-8.24%
|
$4,643,250
$302.47 P/Share
|
|
Nov 06
2020
|
Charles R. Kummeth Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,157
+11.88%
|
$2,163,502
$86.25 P/Share
|
|
Nov 05
2020
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
8,809
-6.26%
|
$2,519,374
$286.21 P/Share
|
|
Nov 05
2020
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,809
+32.92%
|
$951,372
$108.49 P/Share
|
|
Nov 04
2020
|
James Hippel CFO |
SELL
Open market or private sale
|
Direct |
7,100
-13.32%
|
$1,945,400
$274.17 P/Share
|
|
Nov 04
2020
|
James Hippel CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,100
+30.42%
|
$766,800
$108.49 P/Share
|
|
Oct 29
2020
|
Alpna Seth Director |
BUY
Grant, award, or other acquisition
|
Direct |
391
+15.45%
|
-
|
|
Oct 29
2020
|
Julie L Bushman Director |
BUY
Grant, award, or other acquisition
|
Direct |
391
+44.89%
|
-
|
|
Oct 29
2020
|
John L Higgins Director |
BUY
Grant, award, or other acquisition
|
Direct |
391
+8.14%
|
-
|
|
Oct 29
2020
|
Joseph D Keegan Director |
BUY
Grant, award, or other acquisition
|
Direct |
391
+15.45%
|
-
|
|
Oct 29
2020
|
Roeland Nusse Director |
BUY
Grant, award, or other acquisition
|
Direct |
391
+2.97%
|
-
|
|
Oct 29
2020
|
Rupert Vessey Director |
BUY
Grant, award, or other acquisition
|
Direct |
391
+27.46%
|
-
|